12.06.2015 • NewsDede Willamsethylene oxide (EO)Ineos

European Ethylene Oxide Crisis Worsens

The crisis in the European market for ethylene oxide (EO) is becoming increasingly worse.
On June 11, Ineos declared force majeure covering all of Europe for the chemical used in production of monoethylene glycol (MEG) as well as polyester polyols.
The Swiss-based group did not reveal the cause of the FM or when it might be removed, saying only that all reasonable efforts are being made to restore production.
Ineos, which claims to be Europe’s largest EO player with capacity exceeding 900,000 t/y, is the third major player in the region to declare force majeure in the past several weeks.
BASF issued a FM declaration for ethylene oxide produced at two Ludwigshafen facilities on May 19 and Sasol a week later for its plant at Marl, Germany. BASF said its 345,000 t/y unit was off line and a 500,000 t/y plant operating at reduced capacity.
Before the latest outage, reports said the EO market was already short by 35%.
Ineos had been planning to carry out maintenance on its ethylene oxide units at Antwerp, Belgium, and Dormagen, Germany, between mid-June and July and the end of August to the beginning of September, the petrochemical news service Platts said, citing a company source.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.